F&P Healthcare underperforming, but there's upside to come

F&P Healthcare underperforming, but there's upside to come
Rebecca Howard
Fisher & Paykel Healthcare may be underperforming the S&P NZX50 of late, but there looks to be plenty of upside.  There are two main reasons. First, countries are battling new outbreaks of covid-19. Second, its equipment is now in place to treat a wide variety of respiratory ailments — not just covid. Hospital products make up around 75 percent of its operating revenue. The stock jumped 48 percent in 2020 as it ramped up manufacturing capacity and hired scores of new staff to meet demand for its hospital hardware pr...

More Listed Companies

UPDATE: NZX directors mauled in fee vote
Markets

UPDATE: NZX directors mauled in fee vote

Of shares voted on the re-election of NZX chair John McMahon, 27.62% were opposed.

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024